Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia (Q43275817)
Jump to navigation
Jump to search
scientific article published on 16 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia |
scientific article published on 16 September 2009 |
Statements
1 reference
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia (English)
1 reference
J Rosenstock
1 reference
M S Rendell
1 reference
J L Gross
1 reference
P R Fleck
1 reference
C A Wilson
1 reference
Q Mekki
1 reference
16 September 2009
1 reference
1 reference
1 reference
Identifiers
1 reference